India Ratings & Research (Ind-Ra) has affirmed Shilpa Medicare Limited’s long-term issuer rating at ‘IND A+’. The rating on fund-based working capital limits Rs3,450 million (increased from Rs2,450 million) has been affirmed at IND A+/Stable/IND A1.
The credit rating agency has also affirmed ratings on the Term loans with maturity date of March 2026 Rs3,352.2 million (increased from Rs3,093.8 million) at IND A+/Stable.
At around 9.22 am, Shilpa Medicare Ltd was trading at Rs394.05 per piece up by Rs6.75 or 1.74% from its previous closing of Rs387.30 per piece on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
